Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/5756
Title: In vivo pharmacokinetics of radioiodinated urokinase plasminogen activator (uPA) inhibitors for imaging metastatic cancer
Authors: Berghofer, PJ
Greguric, I
Shepherd, R
Katsifis, A
Ranson, M
Vine, K
Keywords: In vivo
Distribution
Iodine
Prostate
Neoplasms
Organs
Issue Date: 1-Jul-2011
Publisher: Wiley-Blackwell
Citation: Berghhofer, P., Greguric, I., Shepherd, R., Katsifis, A., Ranson, M., & Vine, K. (2011). In vivo pharmacokinetics of radioiodinated urokinase plasminogen activator (upa) inhibitors for imaging metastatic cancer. Internal Medicine Journal, 41, 9-10. doi:10.1111/j.1445-5994.2011.02530.x
Abstract: To determine and compare the in vivo tissue distribution, tumour uptake and clearance patterns of PAI2 and PAI2 Δ CD-loop radiolabelled indirectly with Iodine 123 for evaluation as imaging and therapeutic tools in prostate cancer.© 2011, Wiley-Blackwell.
Gov't Doc #: 5277
URI: http://dx.doi.org/10.1111/j.1445-5994.2011.02530.x
http://apo.ansto.gov.au/dspace/handle/10238/5756
ISSN: 1444-0903
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.